Literature DB >> 12112001

Molecular characterization of protein kinase C-alpha binding to lamin A.

Alberto M Martelli1, Roberta Bortul, Giovanna Tabellini, Irene Faenza, Alessandra Cappellini, Renato Bareggi, Lucia Manzoli, Lucio Cocco.   

Abstract

Previous results from our laboratory have identified lamin A as a protein kinase C (PKC)-binding protein. Here, we have identified the regions of PKC-alpha that are crucial for this binding. By means of overlay assays and fusion proteins made of glutathione-S-transferase (GST) fused to elements of rat PKC-alpha, we have established that binding occurs through both the V5 region and a portion of the C2 region (i.e., the calcium-dependent lipid binding (CaLB) domain) of the kinase. In particular, we have found that amino acid 200-217 of the CaLB domain are essential for binding lamin A, as a synthetic peptide corresponding to this stretch of amino acids prevented the interaction between the CaLB domain and lamin A. We also show that the presence of four lysine residues of the CaLB domain (K205, K209, K211, and K213) was essential for the binding. We have determined that binding of elements of PKC-alpha to lamin A does not require the presence of cofactors such as phosphatidylserine (PS) and Ca(2+). We have also found that the binding site of lamin A for the CaLB domain of PKC-alpha is localized in the carboxyl-terminus of the lamin, downstream of amino acid 499. Our findings may prove to be important to clarify the mechanisms regulating PKC function within the nucleus and may also lead to the synthesis of isozyme-specific drugs to attenuate or reverse PKC-dependent nuclear signaling pathways important for the pathogenesis of cancer. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112001     DOI: 10.1002/jcb.10227

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

Review 1.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

Review 2.  A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?

Authors:  Josef Gotzmann; Roland Foisner
Journal:  Histochem Cell Biol       Date:  2005-09-02       Impact factor: 4.304

3.  Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.

Authors:  Frederic F Depreux; Megan J Puckelwartz; Aleksandra Augustynowicz; Don Wolfgeher; Christine M Labno; Dynora Pierre-Louis; Danielle Cicka; Stephen J Kron; James Holaska; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2015-05-06       Impact factor: 6.150

4.  Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B.

Authors:  Richard Park; Joel D Baines
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.

Authors:  V Cenni; P Sabatelli; E Mattioli; S Marmiroli; C Capanni; A Ognibene; S Squarzoni; N M Maraldi; G Bonne; M Columbaro; L Merlini; G Lattanzi
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

Review 6.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

Review 7.  Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function.

Authors:  Viktoria Kheifets; Daria Mochly-Rosen
Journal:  Pharmacol Res       Date:  2007-05-03       Impact factor: 7.658

8.  Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation.

Authors:  Eric W Lin; Graham F Brady; Raymond Kwan; Alexey I Nesvizhskii; M Bishr Omary
Journal:  FASEB J       Date:  2020-05-15       Impact factor: 5.191

Review 9.  Overlapping syndromes in laminopathies: a meta-analysis of the reported literature.

Authors:  Nicola Carboni; Luisa Politano; Matteo Floris; Anna Mateddu; Elisabetta Solla; Stefania Olla; Lorenzo Maggi; Maria Antonietta Maioli; Rachele Piras; Eleonora Cocco; Giovanni Marrosu; Maria Giovanna Marrosu
Journal:  Acta Myol       Date:  2013-05

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.